The Clinical Efficacy of Switching Therapy Between Biological Agents and JAK Inhibitors in the Patients with Rheumatoid Arthritis

被引：0

作者：

Choshi, Tomokazu ^{[1
]}

Mamoto, Kenji ^{[1
]}

Yamada, Yutaro ^{[1
]}

Okano, Tadashi ^{[1
]}

Anno, Shohei ^{[2
]}

Orita, Kazuki ^{[2
]}

Iida, Takahiro ^{[3
]}

Tada, Masahiro ^{[4
]}

Inui, Kentaro ^{[5
]}

Koike, Tatsuya ^{[6
]}

Nakamura, Hiroaki ^{[1
]}

机构：

[1] Osaka Metropolitan Univ, Osaka, Japan

[2] Yodogawa Christians Hosp, Osaka, Japan

[3] Koryokai Hosp, Osaka, Japan

[4] Osaka City Gen Hosp, Osaka, Japan

[5] Saiseikai Nakatsu Hosp, Osaka, Japan

[6] Shirahama Fdn Hlth & Welf, Search Inst Bone & Arthrit Dis SINBAD, Shirahama, Japan

来源：

ARTHRITIS & RHEUMATOLOGY | 2023年 / 75卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

0426

引用

页码：826 / 827

页数：2

共 50 条

[21] JAK Inhibitors for Rheumatoid Arthritis
Marc D. Cohen
Edward C. Keystone
Current Treatment Options in Rheumatology, 2015, 1 (4) : 305 - 319
[22] EFFICACY OF UPADACITINIB IN RHEUMATOID ARTHRITIS PATIENTS WITH INADEQUATE RESPONSE TO FIRST GENERATION JAK INHIBITORS
Kamiya, M.
Mori, S.
Yamazaki, K.
Togawa, D.
ANNALS OF THE RHEUMATIC DISEASES, 2024, 83
[23] ANEMIA IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH JAK INHIBITORS
Takeuchi, Y.
Konishi, M.
Hirabayashi, H.
Tokuda, M.
ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1440 - 1441
[24] Clinical application of biological agents in rheumatoid arthritis
Cheng, Lianying
Rong, Xiaofeng
TRANSPLANT IMMUNOLOGY, 2025, 89
[25] COMPARING THE EFFICACY OF THE BDMARD SWITCHER GROUP AND JAK CYCLER GROUP IN PATIENTS WITH RHEUMATOID ARTHRITIS WITH FAILURE TO THE JAK INHIBITORS
Yamasaki, M.
ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 734 - 735
[26] SAFETY AND ADHERENCE OF THE JAK INHIBITORS IN CLINICAL PRACTICE IN RHEUMATOID ARTHRITIS
Valero, C.
Calvo Garcia, A.
Garcia Castaneda, N.
Ortiz, A.
Llorente, I.
Varas, B.
Castaneda, S.
Garcia de Vicuna, R.
Ramirez, E.
ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1953 - 1954
[27] Clinical Aspects of Janus Kinase (JAK) Inhibitors in the Cardiovascular System in Patients with Rheumatoid Arthritis
Kotyla, Przemyslaw J.
Islam, Md Asiful
Engelmann, Malgorzata
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (19) : 1 - 17
[28] JAK INHIBITORS IN REFRACTORY AND AT-RISK COMORBID PATIENTS WITH RHEUMATOID ARTHRITIS IN CLINICAL PRACTICE
Al Tabaa, O.
Hecquet, S.
Thomas, M.
Carves, S.
Combier, A.
Richard, C. Miceli
Fogel, O.
Molto, A.
Allanore, Y.
Avouac, J.
ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1420 - 1420
[29] Efficacy of the clinical use of iguratimod therapy in patients with rheumatoid arthritis
Okamura, Koichi
Yonemoto, Yukio
Okura, Chisa
Kobayashi, Tsutomu
Takagishi, Kenji
MODERN RHEUMATOLOGY, 2015, 25 (02) : 235 - 240
[30] Efficacy and Safety of JAK Inhibitors for Rheumatoid Arthritis: A Meta-Analysis
Wang, Faping
Tang, Xiaoju
Zhu, Min
Mao, Hui
Wan, Huajing
Luo, Fengming
JOURNAL OF CLINICAL MEDICINE, 2022, 11 (15)

← 1 2 3 4 5 →